Modotuximab

Modotuximab
Monoclonal antibody
Type	Whole antibody
Source	Chimeric
Target	HER1
Clinical data
ATC code	none;
Identifiers
CAS Number	1310460-86-6;
ChemSpider	none;
UNII	1W7BD1M08N;
KEGG	D11125;

Modotuximab (INN; formerly zatuximab) is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER1.^[1]

References

^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

[1] World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).

[1]